Published in Volume 117, Issue 10
J. Clin. Invest.
117(10):
3140-3140 (2007).
doi:10.1172/JCI32205C1.
Copyright © 2007, The American Society for Clinical Investigation
Corrigendum
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling
Chrystal M. Paulos,
Claudia Wrzesinski,
Andrew Kaiser,
Christian S. Hinrichs,
Marcello Chieppa,
Lydie Cassard,
Douglas C. Palmer,
Andrea Boni,
Pawel Muranski,
Zhiya Yu,
Luca Gattinoni,
Paul A. Antony,
Steven A. Rosenberg and
Nicholas P. Restifo
Original citation: J. Clin. Invest.117:2197-2204 (2007). doi:10.1172/JCI32205.
Citation for this corrigendum: J. Clin. Invest.117:3140 (2007). doi:10.1172/JCI32205C1.
During the preparation of the manuscript, two m symbols were omitted from the data on page 2203. The correct text appears below.
Administration of rhIL-2 was performed by i.p. injection twice daily at 3.6-36 mg/dose for a total of 5 doses. Ultrapure LPS (1 mg i.v.; Invivogen) was administered 1 day after ACT.
The authors regret the error.
